Printer Friendly



Air pollution is a potential cause of acute and chronic health effects, ranging from slight upper respiratory tract irritation to chronic heart and lung diseases, chronic bronchitis in adults and acute pulmonary infections in children. It also aggravates the previously experienced symptoms of lung and heart diseases, asthma and lung cancer [1]. Chronic respiratory diseases have been found to be associated with long-term exposure to air pollution [2]. In the working environment, exposure to respirable dust particles is the prospective risk factor associated with long-term pulmonary illnesses. In the occupational environment, workers are prone to several pulmonary disorders [3]. Photocopying machines are the main source of indoor air pollution, involving the emission of ozone, volatile as well as semi-volatile organic compounds. Oxides of nitrogen, particles in the size of nano-range, electromagnetic radiations in the lower frequency range, UV light and certain metals, i.e., arsenic and selenium, have also been reported [4].

Air containing excessive particulate matter, volatile organic compounds and carbon monoxide exerts influence on diverse symptoms, like asthma aggravation, intensified respiratory symptoms, a declined lung function, an increased use of medicinal products, as well as hospital admittance [5]. Upon inhalation, particulate matters penetrate extensively into the lungs and get deposited in the alveolar sacs. The settlement of the particles in these sacs triggers inflammatory responses, and ultimately results in the activation of macrophages and acute inflammation [6]. The documented peak particle number concentration of nano-particles in the photocopying environment is 1x[10.sup.8] particles/[cm.sup.3], owing to an elevated output and persistent operation of machines. Furthermore, photocopying machines are intermittently accommodated in confined spaces without the adequate ventilation, making the condition even worse [7].

Various engineered nanoparticles that are present in toners, including titanium, fumed silica and iron oxide, turn out to be airborne particles. The chemical configuration of airborne particles is composite, and it comprises substantial elements and analytes of toners, inclusive of semi volatile organic compounds, metals, elemental and organic carbon. The organic content of the aerosol encompasses 50% to 70% of the aggregate mass whereas the chemistry is not entirely distinctive and likely to alter with toner formulation [8].

The primary component of a photocopying machine is the toner which generally consists of a resin, i.e., a copolymer of acrylates and styrene (approx. 55%), a pigment, i.e., iron oxides (approx. 50%), and an auxiliary anti-caking agent, i.e., amorphous silica (approx. 3%). Upon heating, the resin exhibits the function of fixing the particles of the pigment to the paper. The particles of the toner with an aerodynamic diameter of 6-8 [micro]m [9] accelerate the intense penetration into the human respiratory system. Extremely fine aerosol particles released from the paper in photocopying machines constitute another source of indoor emissions [10].

In steelworkers with smoking habits, forced vital capacity (FVC) as well as forced expiratory volume in 1 s ([FEV.sub.1]) decreased in response to exposure to respirable dust at average levels [11]. In acute respiratory distress syndrome, the lipid peroxidation level, expressed as arterial malondialdehyde (MDA) concentration, significantly increased [12]. Reduced pulmonary functions (FVC, [FEV.sub.1], [FEV.sub.1]/FVC, as well as peak expiratory flow [PEF]) were observed in the exposed cement factory individuals as compared to the unexposed workers. The exposed workers reported periodic and prolonged phlegm, bronchitis, wheeze, breathlessness, asthma and cough [13].

Lipid peroxidation is considered to be one of the most discernible demonstrations of oxidative stress [14]. The generation of reactive oxygen species can be observed by numerous biomarkers. However, malondialdehyde is the most frequently studied product in relation to the peroxidation of the polyunsaturated fatty acids and the elevation of oxidative stress [15]. The smoking habit has been found to be significantly correlated with the levels of lipid peroxidation as determined by the thiobarbituric acid reactive substances (TBARS) concentration [16].

In general, the intent of this research study was to assess the health effects encountered in relation to the occupation in question, by examining the pulmonary function parameters of the exposed workers and analyzing the effect on lipid peroxidation as an oxidative stress marker with the functional ability to prevent pulmonary disorders and stress in these workers.


Experimental design

A cross-sectional study was conducted in January-September 2017 in accordance with the Helsinki Declaration, upon obtaining an approval from the Institutional Ethical Committee of Lahore College for Women University. The spirometry test was performed on photocopying operators as well as toner fillers (N = 100), and a comparison was made with the control subjects (N = 100). The photocopying operators and toner filling operators, aged 17-65, were included in the study, whereas individuals with previously known chronic illnesses were excluded. In order to scrutinize the effect of the smoking habit, the subjects were classified either as smokers or non-smokers. The subjects were categorized into 2 main groups. All the subjects provided their informed written consent prior to inclusion in the study. The intention of the study was well notified to all the participants. Information was gathered regarding the demographic attributes (age, medical history, socio-economic status, smoking and alcohol consumption, etc.), along with occupation-related particulars (nature of the job, years of exposure, etc.). The same socio-economic status factor was duly considered in the experimental and control subjects.

Pulmonary function test

Pulmonary function evaluation was done using a portable handheld spirometer, model: Spirotron (MDX Instruments, USA). The general specifications for the performance as well as interpretation of the pulmonary function test were followed [17-20]. The pulmonary function indices documented were the FVC, [FEV.sub.1] and [FEV.sub.1]/FVC ratios. All the readings were in the units of liters and percentage predicted values.

Lipid peroxidation assay

Venous blood (3 ml) was collected from the subjects. The blood samples of the experimental as well as control subjects were collected in tubes containing ethylenediaminetetraacetic acid (EDTA) as an anticoagulant. The tubes with blood samples were centrifuged at 3300 rpm for 5 min in order to separate the plasma. The samples underwent the analysis immediately after separation. For the determination of oxidative stress, the most widely acceptable thiobarbituric acid reactive substances assay that quantifies the concentration of malondialdehyde, a product formed as a result of degradation of unstable lipid peroxides [21], was exercised. After centrifugation, the plasma (1 ml) was collected. Normal saline (1 ml) was added into it, and then also 1 ml of trichloroacetic acid (TCA-25%). The entire mixture underwent centrifugation at a speed of 2000 rpm for 20 min. The addition of trichloroacetic acid to the plasma resulted in the sedimentation of protein in the mixture. The supernatant that was protein free was collected to another centrifuge tube. To the protein free supernatant, 0.25 ml of thiobarbituric acid (TBA) at a concentration of 1% was then added, and the mixture was boiled in temperature of 95[degrees]C for 1 h. This yielded a pink-colored product. The intensity of the color pink was determined spectrophotometrically at 532 nm [22]. The equivalents of malondialdehyde were quantified using an extinction coefficient of 1.56x105 M-1 cm-1. The expression of the results was done as [micro]M/l [23].

Statistical analysis

All statistical calculations were performed using SPSS 13.0 (SPSS Inc., USA) for Windows. Descriptive statistical tests were performed to assess the mean and standard deviations of the quantitative variables. For the pulmonary function indices and the total lipid peroxidation level in the plasma, both mean and standard deviations were calculated for each parameter. Student t-test or Mann-Whitney U test was used to compare the mean values of the pulmonary function data and the oxidative stress marker between the experimental and control subjects. To analyze the interrelationship between the pulmonary function data as well as the oxidative stress biomarker, correlation coefficients were determined. The pulmonary function data was expressed in percentage terms of the predicted values as well. The p-value of < 0.05 was considered to be significant. One-way analysis of variance was performed to evaluate the significance of the factors on the dependent variables. All confidence intervals (CI) were calculated at a 95% level.


The demographic patterns, pulmonary function indices and lipid peroxidation as a marker of oxidative stress are presented in Table 1. The workers were monitored in terms of the respiratory symptoms experienced, i.e., cough (31%), sneezing (18%), wheezing (9%) and breathing problems (19%), as well as other health issues, as demonstrated in Table 2. Among smokers in the experimental group, the prevalence of coughing, sneezing, wheezing, phlegm production, chest pain and shortness of breath was calculated, in percentage terms, as 20.69%, 24.14%, 6.90%, 17.24%, 24.14% and 17.24%, respectively, whereas among smokers in the control group, the prevalence of the same health problems amounted to 4.17%, 12.5%, 4.17%, 8.33%, 4.17% and 4.17%, respectively. For coughing, sneezing, wheezing, phlegm production, chest pain and shortness of breath, the prevalence, in percentage terms, was determined at 35.21%, 15.49%, 9.86%, 21.13%, 8.45%, 19.72%, respectively, in the experimental study subjects with no smoking habits, whereas in the non-smoker control study subjects, the percentage rates were found to be 10.53%, 10.53%, 3.95%, 3.95%, 3.95% and 7.89%, respectively, for the above-mentioned health problems. The association between the FVC, FVC% predicted, [FEV.sub.1] and [FEV.sub.1]% predicted was found to be statistically significant (p < 0.05) with the smoking habit (Table 3).

With the increase in age, a reduction in the pulmonary function parameters was observed in both the experimental and control subjects. A negative correlation was found to exist between age and FVC (-0.167), FVC% predicted (-0.12), [FEV.sub.1] (-0.14) and [FEV.sub.1]% predicted (-0.07). Age was found to be statistically significant (p < 0.05) in the case of forced vital capacity (l) and the first forced expiratory volume (l). A reduction in the pulmonary function parameters was observed with the increasing duration of exposure. A negative correlation was revealed between FVC, FVC% predicted and [FEV.sub.1], and the duration of exposure, with the values amounting to -0.081, -0.038, -0.043, respectively. However, it was not found to be statistically significant (p > 0.05), as shown in Table 3.

The severity of airflow obstruction, on the basis of the percent predicted first forced expiratory volume ([FEV.sub.1]% predicted), was subcategorized into [greater than or equal to] 80 as mild, 50-79 as moderate, 30-49 as severe, and < 30 as very severe [20]. Following the specified categorization, the present study revealed that 13.92% of the experimental subjects fell in the mild category, 63.29% in the moderate category, 3.79% in the severe category, and 0% in the very severe category of airflow obstruction.

The quantification of the ventilatory function is very useful. The obstructive ventilatory defect is indicated by the limitation in the airflow, and characterized by reduced [FEV.sub.1], normal or reduced FVC, along with reduced [FEV.sub.1]/FVC. The lower limit of the [FEV.sub.1]/FVC ratio is around 70-75%. In the case of restrictive ventilator defects, the [FEV.sub.1]/FVC ratio remains normal or typically high with reduced [FEV.sub.1] as well as FVC. A reduced FVC ratio, along with a lower [FEV.sub.1]/FVC ratio, is an indicator of a mixed ventilator defect [24,25]. In the current study, spirometry results revealed that 44% of the respondents in the experimental group, and 73% of the subjects in the control group, had a normal ventilatory function. In the experimental study subjects, the percentage values for restrictive, obstructive and mixed ventilatory defects were determined at 47%, 5% and 4%, respectively. In the control subjects, the percentage values for the above-mentioned ventilatory defects were found to be 24%, 2% and 1%, respectively.

The mean values of the oxidative stress marker in the form of the total lipid peroxides level (TBARS [|M/l]), as determined in the plasma of the experimental and control subjects, amounted to 2.25 [+ or -] 0.60 and 1.19 [+ or -] 0.26, respectively. The present study outlines the statistically significant association between the levels of plasma lipid peroxides as TBARS, and the smoking status and the duration of exposure (p < 0.05). A negative correlation exists between the predicted percentage of forced vital capacity, the predicted percentage of forced expiratory volume and the levels of plasma lipid peroxides (TBARS [[micro]M/l]), as shown in Table 4.


A statistically significant elevated incidence of nasal blockage, breathing problems and sputum production was observed among the photocopying operators, as compared to the control group. A higher prevalence of restrictive patterns were also found, as compared to the controls. However, a non-significant result was observed in the percent predicted values of [FEV.sub.1], FVC, [FEV.sub.1]/FVC, PEF, and the mean forced expiratory flow between 25% and 75% of forced vital capacity ([FEF.sub.25-75]) between the control group and the workers involved in the photocopying operation. The level of TBARS in the serum was found to be statistically elevated in the photocopying workers [26].

The correlation between the age factor and the abnormality in the pulmonary function parameters was found to be statistically significant [27]. Tobacco smoke contains several chemical compounds, and there is an association between the smoking habit and the oxidative stress in lungs [28].

During photocopying operations, the workers are exposed to emanated particles by a direct route [10]. Photocopying workers are more prone to pulmonary function impairments, since an increased personal exposure to ultrafine particles and particulate matter 2.5 has been found in this occupational group. A consequent exposure has manifested a remarkable alleviation in FVC, [FEV.sub.1]% predicted, FVC% predicted and [FEV.sub.1]/ FVC%, thereby exhibiting a significant association between personal exposure and pulmonary functions [29].

Oxidative stress elevation has been found in the case of photocopying workers [30,31]. Short-term exposures to the emissions from photocopying machines have been found to cause high oxidative stress as well as inflammatory reactions in their local airways [32].


The current study was designed to assess the association between the pulmonary function indices, oxidative stress and the photocopying occupation. In the present research, a significant difference was observed in both the pulmonary function indices and the lipid peroxidation level in the photocopying workers. The individuals encountering exposure to toner dust during cleaning and maintenance operations reported more respiratory symptoms. The insufficient data availability leads to the worst situation. A significant negative correlation exists between FVC% predicted, [FEV.sub.1]% predicted and Plasma TBARS. Much attention is required to be given to such issues in order to mitigate the adverse health effects.


The authors are thankful to the Chairperson of the Department of Environmental Science for administrative support during the study, and also to the laboratory staff of the Department.


[1.] Kampa M, Castanas E. Human health effects of air pollution. Environ Pollut. 2008;151(2):362-7,

[2.] Groneberg-Kloft B, Kraus T, Mark A, Wagner U, Fischer A. Analysing the causes of chronic cough: relation to diesel exhaust, ozone, nitrogen oxides, sulphur oxides and other environmental factors. J Occup Med Toxicol. 2006;1:6, https://

[3.] Beckett WS. Occupational respiratory diseases. N Engl J Med. 2000;342(6):406-13, 103420607.

[4.] Bar-Sela S, Shoenfeld Y. Photocopy machines and occupational anti-phospholipid syndrome. Isr Med Assoc J. 2008;10(1):52-4.

[5.] Utell MJ, Frampton MW. Acute health effects of ambient air pollution: the ultrafine particle hypothesis. J Aerosol Med. 2000;13(4):355-9, 13.355.

[6.] Oberdorster G, Finkelstein JN, Johnston C, Gelein R, Baggs R, Elder A. Ultrafine particles as inducers of acute lung injury: mechanisms and correlation with age and disease. Res Rep Health Eff Inst. 2000;96:1-88.

[7.] Lee CW, Hsu DJ. Measurements of fine and ultrafine particles formation in photocopy centers in Taiwan. Atmos Environ. 2007;41(31):6598-609,

[8.] Bello D, Martin J, Santeufemio C, Sun Q, Lee Bunker K, Shafer M, et al. Physicochemical and morphological characterisation of nanoparticles from photocopiers: implications for environmental health. Nanotoxicology. 2013;7(5): 989-1003,

[9.] Kim SY, Kim Y, Byeon JH, Lee DY, Hwang J. Emission of submicron aerosol particles in operating a laser beam printer. Int J Precis Eng Manuf. 2009;10(5):33-6, https://

[10.] Wensing M, Kummer T, Riemann AW, Schwampe W. Emissions from electronic devices: examination of computer monitors and laser printers in a 1 m3 emission test chamber. In: International Society of Indoor Air Quality and Climate. The 9th International Conference on Indoor Air and Climate Proceedings; 2002 Jun 30-Jul 5; Monterey: 2002. p. 554-9.

[11.] Chen PC, Doyle PE, Wang JD. Respirable dust exposure and respiratory health in male Taiwanese steelworkers. Ind Health. 2006;44(1):190-9,

[12.] Lichtenstern C, Hofer S, Mollers A, Synder-Ramos S, Spies-Martin D, Martin E, et al. Lipid peroxidation in acute respiratory distress syndrome and liver failure. J Surg Res. 2011; 168(2):243-52,

[13.] Al-Neaimi YI, Gomes J, Lloyd OL. Respiratory illness and ventilator function among workers at a cement factory in a rapidly developing country. Occup Med. 2001;51(6): 367-73,

[14.] Halliwell B, Gutteridge JMC. Role of free radicals and catalytic metal ions in human disease: an overview. Methods Enzymol. 1990;186:1-87,

[15.] Del Rio D, Stewart AJ, Pellegrini N. A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress. Nutr Metab Cardiovasc Dis. 2005;15(4):316-28,

[16.] Pasupathi P, Chinnaswamy P, Saravanan G, Kumar US. Effect of chronic smoking on lipid peroxidation and antioxidant status in gastric carcinoma patients. Bangladesh Med Res Counc Bull. 2009;35(1):1-6,

[17.] Miller MR, Crapo R, Hankinson J, Brusasco V, Burgos F, Casaburi R, et al. General considerations for lung function testing. Eur Respir J. 2005;26(1):153-61,

[18.] Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, et al. Interpretative strategies for lung function tests. Eur Respir J. 2005;26(5):948-68,

[19.] Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319-38,

[20.] Ranu H, Wilde M, Madden B. Pulmonary Function Tests. Ulster Med J. 2011;80(2):84-90.

[21.] Vaya J. Exogenous markers for the characterization of human disease associated with oxidative stress. Biochimie. 2013;95(3):578-84,

[22.] Ilieva V, Nikolova G, Gadjeva V. Lipid peroxidation and catalase activities in patients with chronic obstructive pulmonary disease: A comparative study with other pulmonary diseases. Trakia J Sci. 2014;12(2):177-81.

[23.] Ali M, Rizvi TF, Perveen Z, Mishra GC, Kumar R, Kumar A. Lipid peroxidation as a biomarker for exposure of pesticides. Int J Adv Res. 2014;2(9):717-20.

[24.] Johns DP, Pierce R. Spirometry: The measurement and interpretation of ventilatory function in clinical practice. Melbourne: National Asthma Council; 1995, updated 2008. p. 1-24.

[25.] Moore VC. Spirometry: step by step. Breathe. 2012;8(3): 233-40,

[26.] Elango N, Kasi V, Vembhu B, Poornima JG. Chronic exposure to emissions from photocopiers in copy shops cause oxidative stress and systematic inflammation among photocopiers in India. Environ Health. 2013;12(1):78, https://

[27.] Dehghan F, Mohammadi S, Sadeghi Z, Attarchi M. Respiratory complaints and spirometric parameters in tile and ceramic factory workers. Tanaffos. 2009;8(4):19-25.

[28.] Doruk S, Ozyurt H, Inonu H, Erkorkmaz U, Saylan O, Seyfikli Z. Oxidative status in the lungs associated with tobacco smoke exposure. Clin Chem Lab Med. 2011;49(12): 2007-12,

[29.] Bahruddin NA, Jalaludin J, Praveena SM. PM2.5 & UFP exposure and its association with respiratory health illness among photocopy workers in Selangor. Asia Pacific Environ Occup Health J. 2015;1(1):36-43.

[30.] Gadhia PK, Patel D, Solanki KB, Tamakuwala DN, Pithawala MA. A preliminary cytogenetic and haematological study of photocopying machine operators. Indian J Occup Environ Med. 2005;9(1):22-5,

[31.] Kleinsorge EC, Erben M, Galan MG, Barison C, Gonsebatt ME, Simoniello MF. Assessment of oxidative status and genotoxicity in photocopier operators: a pilot study. Biomarkers. 2011;16(8):642-8,

[32.] Khatri M, Bello D, Gaines P, Martin J, Pal AK, Gore R, et al. Nanoparticles from photocopiers induce oxidative stress and upper respiratory tract inflammation in healthy volunteers. Nanotoxicology. 2013;7(5):1014-27, https://

Houda Javed (1), Nadia Ghani (1), Natasha Ghani (2), Ammara Fatima (1)

(1) Lahore College for Women University, Lahore, Pakistan Department of Environmental Science

(2) Children's Hospital and Institute of Child Health, Lahore, Pakistan Neurological Department

Corresponding author: Houda Javed, Lahore College for Women University, Department of Environmental Science, Jail Road 65, 54000 Lahore, Pakistan, e-mail:

Received: September 19, 2018, accepted: December 12, 2018
Table 1. Baseline attributes of the experimental and control subjects

              Attributes                   Experimental group

Gender [n]
  male                                            100
  female                                           0
Age [years] (M [+ or -] SD)               28.19 [+ or -] 7.58
BMI [kg/[m.sup.2]]
  M [+ or -] SD                           23.57 [+ or -] 4.26
  range                                       15.81-35.16
Smoking [n]
  yes                                              29
  no                                               71
Pack years (M [+ or -] SD)                1.115 [+ or -] 2.66
Employment [years]
  M [+ or -] SD                             6.5 [+ or -] 6.54
  range                                         0.5-24.0
Education [n]
  primary                                          13
  secondary                                        30
  higher                                           57
FVC [l] (M [+ or -] SD)                    2.62 [+ or -] 0.66
FVC% predicted [%] (M [+ or -] SD)        66.39 [+ or -] 17.62
[FEV.sub.1] [l] (M [+ or -] SD)            2.43 [+ or -] 0.52
[FEV.sub.1]% predicted [%]                71.86 [+ or -] 15.70
  (M [+ or -] SD)
[FEV.sub.1]/FVC ratio [%]                 93.93 [+ or -] 8.00
  (M [+ or -] SD)
Plasma TBARS [[micro]M/l]                  2.25 [+ or -] 0.60
  (M [+ or -] SD)

              Attributes                     Control group

Gender [n]
  male                                            100
  female                                           0
Age [years] (M [+ or -] SD)               31.08 [+ or -] 10.97
BMI [kg/[m.sup.2]]
  M [+ or -] SD                           23.45 [+ or -] 4.09
  range                                       14.88-33.87
Smoking [n]
  yes                                              24
  no                                               76
Pack years (M [+ or -] SD)                0.988 [+ or -] 0.286
Employment [years]
  M [+ or -] SD                                    --
Education [n]
  primary                                          16
  secondary                                        31
  higher                                           53
FVC [l] (M [+ or -] SD)                    2.85 [+ or -] 0.94
FVC% predicted [%] (M [+ or -] SD)        83.57 [+ or -] 11.72
[FEV.sub.1] [l] (M [+ or -] SD)            2.70 [+ or -] 0.79
[FEV.sub.1]% predicted [%]                75.08 [+ or -] 18.37
  (M [+ or -] SD)
[FEV.sub.1]/FVC ratio [%]                 95.96 [+ or -] 6.42
  (M [+ or -] SD)
Plasma TBARS [[micro]M/l]                 1.198 [+ or -] 0.25
  (M [+ or -] SD)

              Attributes                           p

Gender [n]                                        --
Age [years] (M [+ or -] SD)                0.175 ([dagger])
BMI [kg/[m.sup.2]]                         0.853 ([dagger])
  M [+ or -] SD
Smoking [n]                                       --
Pack years (M [+ or -] SD)                 0.403 ([dagger])
Employment [years]                                --
  M [+ or -] SD
Education [n]                                     --
FVC [l] (M [+ or -] SD)                    0.261 ([dagger])
FVC% predicted [%] (M [+ or -] SD)        0.000 ([dagger]) **
[FEV.sub.1] [l] (M [+ or -] SD)            0.052 ([dagger])
[FEV.sub.1]% predicted [%]                 0.338 ([dagger])
  (M [+ or -] SD)
[FEV.sub.1]/FVC ratio [%]                 0.037 ([dagger]) *
  (M [+ or -] SD)
Plasma TBARS [[micro]M/l]                 0.000 ([dagger]) **
  (M [+ or -] SD)

[FEV.sub.1]/FVC ratio--the forced expiratory volume in 1 s to
forced vital capacity ratio, TBARS--thiobarbituric acid
reactive substances.

([dagger]) Mann-Whitney U Test.

* p-value significant at the level of p < 0.05.

** p-value significant at the level of p < 0.01.

Table 2. Physical ailments in the experimental and control subjects

       Symptom           Experimental     Control
                          group [n]      group [n]

Headache                      30             11
Fatigue                       39             12
Nasal irritation              10             2
Eye irritation                20             3
Skin irritation               8              1
Throat irritation             11             5
Dizziness                     15             7
Insomnia                      11             5
Poor memory                   9              3
Poor appetite                 11             2
Vision problem                10             6
Hearing problem               03             1
Coughing                      31             9
Sneezing                      18             11
Wheezing                      9              4
Phlegm production             20             5
Chest pain                    13             4
Shortness of breath           19             7

       Symptom                 OR (CI)

Headache                 3.467 (1.624-7.403)
Fatigue                  4.688 (2.271-9.678)
Nasal irritation         5.444 (1.161-25.522)
Eye irritation           8.083 (2.318-28.188)
Skin irritation          8.608 (1.056-70.172)
Throat irritation        2.348 (0.785-7.026)
Dizziness                2.345 (0.912-6.027)
Insomnia                 2.348 (0.785-7.026)
Poor memory              3.198 (0.839-12.183)
Poor appetite            6.056 (1.307-28.074)
Vision problem           1.741 (0.608-4.987)
Hearing problem          3.062 (0.313-29.949)
Coughing                 4.543 (2.030-10.165)
Sneezing                 1.776 (0.792-3.984)
Wheezing                 2.734 (0.706-7.978)
Phlegm production        4.75 (1.706-13.227)
Chest pain               3.586 (1.127-11.413)
Shortness of breath      3.116 (1.246-7.792)

       Symptom                        p

Headache                0.001 ([dagger]) **
Fatigue                 0.000 ([dagger]) **
Nasal irritation        0.033 ([dagger][dagger]) *
Eye irritation          0.000 ([dagger][dagger]) **
Skin irritation         0.035 ([dagger][dagger]) *
Throat irritation       0.118 ([dagger])
Dizziness               0.071 ([dagger])
Insomnia                0.118 ([dagger])
Poor memory             0.134 ([dagger][dagger])
Poor appetite           0.018 ([dagger][dagger]) *
Vision problem          0.297 ([dagger])
Hearing problem         0.621 ([dagger][dagger])
Coughing                0.000 ([dagger]) **
Sneezing                0.160 ([dagger])
Wheezing                0.251 ([dagger][dagger])
Phlegm production       0.001 ([dagger]) **
Chest pain              0.040 ([dagger][dagger]) *
Shortness of breath     0.012 ([dagger]) **

([dagger]) Chi square test.

([dagger][dagger]) Fisher's exact test.

* p-value significant at the level of p < 0.05.

** p-value significant at the level of p < 0.01.

Table 3. Pulmonary function parameters with respect to the smoking
habit, age and duration of exposure in the control and experimental

                          Control group (N = 100)

  Characteristics      sample           FVC [1]
                      size [n]      (M [+ or -] SD)

Smoking habit
  yes                    24        2.44 [+ or -] 0.55
  no                     76        3.09 [+ or -] 0.93
  P                      --             0.000 **
Age [years]
  < 30                   54        3.07 [+ or -] 1.06
  [greater than          46        2.59 [+ or -] 0.7
  or equal to] 30
  P                      --              0.293
Exposure [years]
  < 10                   --                --
  [greater than
  or equal to] 10        --                --
  P                      --                --

                                 Control group (N = 100)

  Characteristics       FVC% predicted [%]       [FEV.sub.1] [1]
                         (M [+ or -] SD)         (M [+ or -] SD)

Smoking habit
  yes                  73.33 [+ or -] 6.8       2.38 [+ or -] 0.51
  no                    86.8 [+ or -] 11.08     2.92 [+ or -] 0.76
  P                          0.000 **                0.000 **
Age [years]
  < 30                 85.33 [+ or -] 12.41     2.89 [+ or -] 0.86
  [greater than         81.5 [+ or -] 10.53     2.48 [+ or -] 0.62
  or equal to] 30
  P                          0.010 *                  0.297
Exposure [years]
  < 10                          --                      --
  [greater than
  or equal to] 10               --                      --
  P                             --                      --

                                  Control group (N = 100)

  Characteristics         [FEV.sub.1]%           [FEV.sub.1]/FVC
                          predicted [%]             ratio [%]
                         (M [+ or -] SD)          (M [+ or -] SD)

Smoking habit
  yes                  59.5 [+ or -] 12.57        98 [+ or -] 3.66
  no                     80 [+ or -] 17.16     95.39 [+ or -] 7.01
  P                          0.000 **                  0.118
Age [years]
  < 30                77.26 [+ or -] 17.55     95.70 [+ or -] 6.78
  [greater than       72.52 [+ or -] 19.15     96.26 [+ or -] 6.05
  or equal to] 30
  P                           0.270                    0.766
Exposure [years]
  < 10                          --                      --
  [greater than
  or equal to] 10               --                      --
  P                             --                      --

                       Experimental group (N = 100)

  Characteristics      sample           FVC [1]
                      size [n]      (M [+ or -] SD)

Smoking habit
  yes                    29        2.08 [+ or -] 0.53
  no                     71        2.84 [+ or -] 0.58
  P                      --             0.000 **
Age [years]
  < 30                   65        2.67 [+ or -] 0.6
  [greater than          35        2.52 [+ or -] 0.69
  or equal to] 30
  P                      --             0.046 *
Exposure [years]
  < 10                   76        2.65 [+ or -] 0.65
  [greater than
  or equal to] 10        24        2.53 [+ or -] 0.7
  P                      --              0.452

                               Experimental group (N = 100)

  Characteristics       FVC% predicted [%]       [FEV.sub.1] [1]
                         (M [+ or -] SD)         (M [+ or -] SD)

Smoking habit
  yes                  55.21 [+ or -] 15.1      2.04 [+ or -] 0.5
  no                   70.95 [+ or -] 16.6      2.59 [+ or -] 0.44
  P                          0.000 **                0.000 **
Age [years]
  < 30                 67.71 [+ or -] 17.38     2.46 [+ or -] 0.5
  [greater than        63.94 [+ or -] 18.04     2.38 [+ or -] 0.55
  or equal to] 30
  P                           0.100                  0.008 **
Exposure [years]
  < 10                 66.39 [+ or -] 17.33     2.43 [+ or -] 0.49
  [greater than
  or equal to] 10      66.37 [+ or -] 18.89     2.42 [+ or -] 0.59
  P                           0.996                   0.943

                               Experimental group (N = 100)

  Characteristics         [FEV.sub.1]%           [FEV.sub.1]/FVC
                          predicted [%]             ratio [%]
                         (M [+ or -] SD)          (M [+ or -] SD)

Smoking habit
  yes                   63.2 [+ or -] 16.45     98.24 [+ or -] 2.7
  no                   75.39 [+ or -] 14.0      92.16 [+ or -] 8.77
  P                          0.000 **                0.000 **
Age [years]
  < 30                 72.42 [+ or -] 14.7      92.97 [+ or -] 8.44
  [greater than        70.83 [+ or -] 17.55     95.71 [+ or -] 6.89
  or equal to] 30
  P                          0.021 *                   0.229
Exposure [years]
  < 10                 71.09 [+ or -] 14.56     93.05 [+ or -] 8.67
  [greater than
  or equal to] 10      74.29 [+ or -] 19.02     96.71 [+ or -] 4.52
  P                           0.387                   0.051 *

[FEV.sub.1]/FVC ratio--the forced expiratory volume in 1 s to
forced vital capacity ratio.

* p-value significant at the level of p < 0.05.

** p-value significant at the level of p < 0.01.

Table 4. Correlation coefficient between the pulmonary function
data and plasma thiobarbituric acid reactive substances (TBARS) as
malondialdehyde (MDA) in the experimental and control groups

          Parameter             Plasma TBARS

FVC% predicted [%]
  experimental group              -0.221 *
  control group                   -0.284 *
[FEV.sub.1]% predicted [%]
  experimental group              -0.178 *
  control group                   -0.336 *

* The correlation is significant at the level of 0.05.
COPYRIGHT 2019 Nofer Institute of Occupational Medicine
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2019 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:ORIGINAL PAPER
Author:Javed, Houda; Ghani, Nadia; Ghani, Natasha; Fatima, Ammara
Publication:Medycyna Pracy
Geographic Code:9PAKI
Date:Jul 1, 2019

Terms of use | Privacy policy | Copyright © 2022 Farlex, Inc. | Feedback | For webmasters |